During the past decade, Bristol Haematology and Oncology Centre conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 28 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 15 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Haematology and Oncology Centre" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 18 trials, followed by "Hoffmann-La Roche" with 17 trials sponsored, "Medical Research Council" with 11 trials sponsored, "Institute of Cancer Research, United Kingdom" with 9 trials sponsored and "University College, London" with 9 trials sponsored. Other sponsors include 93 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Haematology and Oncology Centre" #1 collaborator was "Cancer Research UK" with 19 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 4 trials as a collaborator, "Celgene" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Haematology and Oncology Centre" are "Prostate Cancer" (10 trials), "Breast Cancer" (9 trials), "Colorectal Cancer" (9 trials), "Lymphoma" (6 trials) and "Bladder Cancer" (5 trials). Many other conditions were trialed in "Bristol Haematology and Oncology Centre" in a lesser frequency.

Most popular intervention types in "Bristol Haematology and Oncology Centre" are "Drug" (127 trials), "Radiation" (31 trials), "Procedure" (30 trials), "Biological" (25 trials) and "Other" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "radiation therapy" (16 trials), "adjuvant therapy" (12 trials), "capecitabine" (9 trials) and "cyclophosphamide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Haematology and Oncology Centre" are 133 trials for "All" genders, 16 trials for "Male" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Bristol Haematology and Oncology Centre". 1 are not yet recruiting, 25 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Bristol Haematology and Oncology Centre, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Haematology and Oncology Centre, 8 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".